CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)(EUR (€)) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		287 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Revenue
Sales	€ 0	€ 0	€ 660
License fees	0	0	4,381
Research and development support	527	0	527
Interest	0	0	47
Gain on extinguishment of debt	0	0	774
Gain on sales of equipment	0	0	69
Government grants	0	0	107
Total revenue	527	0	6,565
Expenses
Research and development	369	214	27,734
General and administrative	382	320	25,968
Bank fee	1	1	948
Induced conversion cost	0	0	807
Interest	678	622	15,201
Change in the fair value of acquisition-related contingent consideration	0	(6,279)	(3,314)
Goodwill impairment	0	0	209
Depreciation	7	4	833
Amortization of intangibles	0	0	481
Impairment of license contract	0	0	2,213
Directors' fees	5	5	401
Other	(18)	54	72
Total expenses	1,424	(5,059)	71,553
Loss before income tax provision	(897)	5,059	(64,988)
Income tax provision	(12)	(4)	(86)
Net income (loss)	(909)	5,055	(65,074)
Other comprehensive income (loss) Foreign currency translation adjustment	(18)	(3)	683
Comprehensive income (loss)	€ (927)	€ 5,052	€ (64,391)
Basic earnings per share (in Euro per share)	€ 0	€ 0.02
Diluted earnings per share (in Euro per share)	€ 0	€ 0.01